CTI BioPharma Corp. is on the Cruelty Free Investing use of animals list because they conduct Pre-clinical studies of their drugs on animals to assess a product’s safety profile.
CTI BioPharma Corp. operates as a biopharmaceutical company, which is focuses on the development, acquisition, and commercialization of novel treatments for cancer. Its products include Pixuvri, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. [Source: MarketWatch]
Company Website: http://www.ctibiopharma.com